Barbanti; Elena

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barbanti; Elena.The latest application filed is for "high purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof".

Company Profile

0.12.12

Barbanti; Elena - Cologno Monzese IT
Barbanti; Elena - Cologno Monzese MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof Grant 8,846,763 - Barbanti , et al. September 30, 2	2014-09-30
Alpha-aminoamide derivatives useful in the treatment of addictive disorders Grant 8,697,738 - Besana , et al. April 15, 2	2014-04-15
High Purity 2-[4-(3- Or 2-fluorobenzyloxy)benzylamino] Propanamides And Methods Of Use Thereof App 20140051758 - BARBANTI; Elena ; et al.	2014-02-20
High purity 2-[4-(3- OR 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof Grant 8,530,701 - Barbanti , et al. September 10, 2	2013-09-10
Alpha-aminoamide Derivatives Useful In The Treatment Of Restless Legs Syndrome App 20130217747 - Besana; Claudia ; et al.	2013-08-22
.alpha.-Aminoamide derivatives useful in the treatment of restless legs syndrome Grant 8,445,513 - Besana , et al. May 21, 2	2013-05-21
Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders Grant 8,445,539 - Izzo , et al. May 21, 2	2013-05-21
Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides Grant 8,278,485 - Barbanti , et al. October 2, 2	2012-10-02
Process For The Production Of 2-[4-(3- And 2-fluorobenzyloxy) Benzylamino] Propanamides App 20120157712 - BARBANTI; ELENA ; et al.	2012-06-21
Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides Grant 8,076,515 - Barbanti , et al. December 13, 2	2011-12-13
Use Of (halobenzyloxy) Benzylamino-propanamides For The Manufacture Of Medicaments Active As Sodium And/or Calcium Channel Selective Modulators App 20110184068 - Barbanti; Elena ; et al.	2011-07-28
Alpha-aminoamide Derivatives Useful In The Treatment Of Psychiatric Disorders App 20110014304 - Izzo; Emanuela ; et al.	2011-01-20
High Purity 2-[4-(3- Or 2-fluorobenzyloxy)benzylamino]propanamides And Methods Of Use Thereof App 20100324141 - Barbanti; Elena ; et al.	2010-12-23
Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders Grant 7,718,815 - Barbanti , et al. May 18, 2	2010-05-18
Alpha-aminoamide Derivatives Useful As Anti-inflammatory Agents App 20100016440 - Salvati; Patricia ; et al.	2010-01-21
Process For The Production Of 2-[4-(3- And 2-fluorobenzyloxy) Benzylamino] Propanamides App 20090156678 - Barbanti; Elena ; et al.	2009-06-18
Alpha-Aminoamide Derivatives Useful in the Treatment of Lower Urinary Tract Disorders App 20080132567 - Barbanti; Elena ; et al.	2008-06-05
(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators App 20080096965 - Barbanti; Elena ; et al.	2008-04-24
Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents App 20070276046 - Salvati; Patricia ; et al.	2007-11-29
Alpha-Aminoamide Derivatives Useful In The Treatment Of Restless Legs Syndrome And Addictive Disorders App 20070203182 - Besana; Claudia ; et al.	2007-08-30
Monoclonal antibodies against human Tumor Necrosis Factor .alpha. Grant 5,436,154 - Barbanti , et al. July 25, 1	1995-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.